Literature DB >> 27346356

FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.

Xu Li1, Wenqi Wang1, Yuanxin Xi2, Min Gao1, MyKim Tran1, Kathryn E Aziz1, Jun Qin3, Wei Li2, Junjie Chen4.   

Abstract

By combining the results of a large-scale proteomic analysis of the human transcription factor interaction network with knowledge databases, we identified FOXR2 as one of the top-ranked candidate proto-oncogenes. Here, we show that FOXR2 forms a stable complex with MYC and MAX and subsequently regulates cell proliferation by promoting MYC's transcriptional activities. We demonstrate that FOXR2 is highly expressed in several breast, lung, and liver cancer cell lines and related patient tumor samples, while reduction of FOXR2 expression in a xenograft model inhibits tumor growth. These results indicate that FOXR2 acts with MYC to promote cancer cell proliferation, which is a potential tumor-specific target for therapeutic intervention against MYC-driven cancers.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FOXR2; MYC; forkhead box; protein-protein interaction

Mesh:

Substances:

Year:  2016        PMID: 27346356      PMCID: PMC4946253          DOI: 10.1016/j.celrep.2016.06.004

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  54 in total

1.  BIND: the Biomolecular Interaction Network Database.

Authors:  Gary D Bader; Doron Betel; Christopher W V Hogue
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

2.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

3.  Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.

Authors:  I Bièche; I Laurendeau; S Tozlu; M Olivi; D Vidaud; R Lidereau; M Vidaud
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

Review 4.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

Review 5.  Apoptotic signaling by c-MYC.

Authors:  B Hoffman; D A Liebermann
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

6.  Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology.

Authors:  T S Keshava Prasad; Kumaran Kandasamy; Akhilesh Pandey
Journal:  Methods Mol Biol       Date:  2009

7.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

Authors:  R Taub; I Kirsch; C Morton; G Lenoir; D Swan; S Tronick; S Aaronson; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Identification and characterization of human FOXN5 and rat Foxn5 genes in silico.

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Oncol       Date:  2004-05       Impact factor: 5.650

9.  Cytoscape 2.8: new features for data integration and network visualization.

Authors:  Michael E Smoot; Keiichiro Ono; Johannes Ruscheinski; Peng-Liang Wang; Trey Ideker
Journal:  Bioinformatics       Date:  2010-12-12       Impact factor: 6.937

10.  Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

Authors:  Xu Li; Wenqi Wang; Jiadong Wang; Anna Malovannaya; Yuanxin Xi; Wei Li; Rudy Guerra; David H Hawke; Jun Qin; Junjie Chen
Journal:  Mol Syst Biol       Date:  2015-01-21       Impact factor: 11.429

View more
  10 in total

1.  Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

Authors:  Anthony P Y Liu; Brian Gudenas; Tong Lin; Brent A Orr; Paul Klimo; Rahul Kumar; Eric Bouffet; Sridharan Gururangan; John R Crawford; Stewart J Kellie; Murali Chintagumpala; Michael J Fisher; Daniel C Bowers; Tim Hassall; Daniel J Indelicato; Arzu Onar-Thomas; David W Ellison; Frederick A Boop; Thomas E Merchant; Giles W Robinson; Paul A Northcott; Amar Gajjar
Journal:  Acta Neuropathol       Date:  2019-12-04       Impact factor: 17.088

Review 2.  Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential.

Authors:  Yuhao Zhou; Yuan Zhan; Weiling Jiang; Huiguo Liu; Shuang Wei
Journal:  Oxid Med Cell Longev       Date:  2022-06-15       Impact factor: 7.310

3.  LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism.

Authors:  Xin Zheng; Han Han; Guang-Ping Liu; Yan-Xiu Ma; Ruo-Lang Pan; Ling-Jie Sang; Rui-Hua Li; Luo-Jia Yang; Jeffrey R Marks; Wenqi Wang; Aifu Lin
Journal:  EMBO J       Date:  2017-09-28       Impact factor: 11.598

4.  FoxR2 promotes glioma proliferation by suppression of the p27 pathway.

Authors:  Xuejiao Liu; Ning Liu; Chenglong Yue; Dacheng Wang; Zhenglei Qi; Yiming Tu; Guokun Zhuang; Di Zhou; Shangfeng Gao; Mingshan Niu; Rutong Yu
Journal:  Oncotarget       Date:  2017-04-27

5.  Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis.

Authors:  Nicolas Rosewick; Keith Durkin; Maria Artesi; Ambroise Marçais; Vincent Hahaut; Philip Griebel; Natasa Arsic; Véronique Avettand-Fenoel; Arsène Burny; Carole Charlier; Olivier Hermine; Michel Georges; Anne Van den Broeke
Journal:  Nat Commun       Date:  2017-05-23       Impact factor: 14.919

6.  Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.

Authors:  Yangle Li; Xiongbing Zu; Xiheng Hu; Long Wang; Wei He
Journal:  Med Sci Monit       Date:  2019-11-25

7.  Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor.

Authors:  Diane A Flasch; Xiaolong Chen; Bensheng Ju; Xiaoyu Li; James Dalton; Heather L Mulder; John Easton; Lu Wang; Suzanne J Baker; Jason Chiang; Jinghui Zhang
Journal:  Acta Neuropathol       Date:  2022-04-11       Impact factor: 15.887

8.  Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.

Authors:  Anthony P Y Liu; Bryan K Li; Elke Pfaff; Brian Gudenas; Alexandre Vasiljevic; Brent A Orr; Christelle Dufour; Matija Snuderl; Matthias A Karajannis; Marc K Rosenblum; Eugene I Hwang; Ho-Keung Ng; Jordan R Hansford; Alexandru Szathmari; Cécile Faure-Conter; Thomas E Merchant; Max Levine; Nancy Bouvier; Katja von Hoff; Martin Mynarek; Stefan Rutkowski; Felix Sahm; Marcel Kool; Cynthia Hawkins; Arzu Onar-Thomas; Giles W Robinson; Amar Gajjar; Stefan M Pfister; Eric Bouffet; Paul A Northcott; David T W Jones; Annie Huang
Journal:  Acta Neuropathol       Date:  2021-02-22       Impact factor: 15.887

9.  Mechanism of piR-DQ590027/MIR17HG regulating the permeability of glioma conditioned normal BBB.

Authors:  Xue Leng; Jun Ma; Yunhui Liu; Shuyuan Shen; Hai Yu; Jian Zheng; Xiaobai Liu; Libo Liu; Jiajia Chen; Lini Zhao; Xuelei Ruan; Yixue Xue
Journal:  J Exp Clin Cancer Res       Date:  2018-10-11

10.  FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome.

Authors:  Felix Schmitt-Hoffner; Sjoerd van Rijn; Umut H Toprak; Monika Mauermann; Felix Rosemann; Anke Heit-Mondrzyk; Jens-Martin Hübner; Aylin Camgöz; Sabine Hartlieb; Stefan M Pfister; Kai-Oliver Henrich; Frank Westermann; Marcel Kool
Journal:  J Clin Oncol       Date:  2021-06-10       Impact factor: 50.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.